NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
11.48
Dollar change
+0.03
Percentage change
0.26
%
IndexS&P 500 P/E- EPS (ttm)-7.29 Insider Own17.66% Shs Outstand865.20M Perf Week1.15%
Market Cap9.94B Forward P/E7.76 EPS next Y1.48 Insider Trans0.00% Shs Float712.71M Perf Month2.18%
Enterprise Value39.23B PEG- EPS next Q0.26 Inst Own61.14% Short Float2.69% Perf Quarter2.59%
Income-6298.00M P/S0.06 EPS this Y-40.15% Inst Trans-2.33% Short Ratio1.79 Perf Half Y24.92%
Sales154.58B P/B1.38 EPS next Y-14.17% ROA-8.27% Short Interest19.19M Perf YTD23.04%
Book/sh8.30 P/C11.97 EPS next 5Y-17.11% ROE-60.49% 52W High13.25 -13.36% Perf Year-26.69%
Cash/sh0.96 P/FCF17.13 EPS past 3/5Y- - ROIC-18.40% 52W Low8.08 42.08% Perf 3Y-71.92%
Dividend Est.0.75 (6.53%) EV/EBITDA13.87 Sales past 3/5Y3.67% 1.53% Gross Margin15.55% Volatility0.70% 0.65% Perf 5Y-73.18%
Dividend TTM0.50 (4.36%) EV/Sales0.25 EPS Y/Y TTM-8.21% Oper. Margin0.26% ATR (14)0.09 Perf 10Y-86.92%
Dividend Ex-DateNov 18, 2024 Quick Ratio0.32 Sales Y/Y TTM6.22% Profit Margin-4.07% RSI (14)66.01 Recom2.83
Dividend Gr. 3/5Y-13.19% -7.13% Current Ratio0.60 EPS Q/Q-150.83% SMA201.25% Beta0.75 Target Price12.09
Payout- Debt/Eq4.18 Sales Q/Q7.25% SMA502.49% Rel Volume0.81 Prev Close11.45
Employees312000 LT Debt/Eq3.77 EarningsJun 26 BMO SMA20011.50% Avg Volume10.74M Price11.48
IPODec 31, 2014 Option/ShortYes / Yes EPS/Sales Surpr.16.14% 5.83% Trades Volume8,717,416 Change0.26%
Date Action Analyst Rating Change Price Target Change
Feb-28-25Downgrade Deutsche Bank Hold → Sell $11 → $9
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Today 11:07AM
12:01AM
Jun-29-25 01:40PM
Jun-27-25 05:26PM
12:21PM
09:22AM Loading…
09:22AM
05:52AM
Jun-26-25 06:02PM
04:35PM
12:22PM
11:03AM
10:54AM
09:52AM
09:30AM
09:05AM
08:10AM Loading…
08:10AM
08:06AM
07:50AM
07:42AM
07:19AM
07:14AM
07:12AM
07:06AM
07:06AM
07:00AM
04:58AM
04:55AM
04:18AM
Jun-25-25 01:58PM
09:34AM
03:27AM Loading…
03:27AM
Jun-24-25 11:00PM
08:00AM
06:30AM
04:56AM
Jun-23-25 09:15AM
Jun-22-25 02:00PM
10:21AM
07:35AM
06:00AM
Jun-20-25 10:02AM
08:55AM
08:10AM
Jun-18-25 09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
07:10AM
Jun-17-25 03:00PM
11:22AM
07:00AM
Jun-16-25 05:15PM
08:59AM
Jun-12-25 09:00AM
Jun-11-25 10:01PM
10:56AM
05:30AM
04:15AM
Jun-10-25 01:26PM
Jun-09-25 11:30PM
Jun-06-25 01:21PM
Jun-05-25 05:15PM
08:31AM
Jun-02-25 05:45PM
06:20AM
12:02AM
May-27-25 05:45PM
09:25AM
May-22-25 08:26AM
May-21-25 05:45PM
07:20AM
May-20-25 05:33PM
01:46PM
10:27AM
09:00AM
May-19-25 10:22AM
07:19AM
May-16-25 09:59AM
May-15-25 05:45PM
08:50AM
May-14-25 03:00PM
07:51AM
May-13-25 06:20PM
May-12-25 03:54PM
May-09-25 06:46PM
May-08-25 05:45PM
11:30AM
May-06-25 12:35AM
May-05-25 06:11PM
May-02-25 05:45PM
Apr-30-25 03:22AM
03:15AM
Apr-29-25 09:07AM
Apr-28-25 09:50AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pessina StefanoExecutive Chairman of BoardApr 27 '25Buy11.01832,2589,163,161145,621,079Apr 29 08:49 PM
Pessina StefanoExecutive Chairman of BoardApr 27 '25Sale11.01832,2589,163,161657,308Apr 29 08:49 PM
Walgreens Boots Alliance, Inc.Former 10% ownerFeb 18 '25Sale21.1612,000,000253,920,00011,239,996Feb 20 04:30 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 06 '25Sale244.511,286,376314,531,79612,570,000Feb 10 07:35 PM
Walgreens Boots Alliance HoldiAffiliateFeb 06 '25Proposed Sale246.131,081,885266,284,355Feb 06 07:55 PM
Walgreens Boots Alliance, Inc.10% OwnerSep 11 '24Sale11.1311,619,998129,330,57823,239,996Sep 13 07:04 PM
Walgreens Boots Alliance, Inc.10% OwnerAug 01 '24Sale240.564,438,1711,067,646,41619,980,000Aug 05 06:44 PM
Walgreens Boots Alliance HoldiAffiliateAug 01 '24Proposed Sale244.463,398,929830,902,183Aug 01 08:56 PM